Anika Therapeutics, Inc. Property, Plant and Equipment, Gross
Anika Therapeutics, Inc. (ANIK) had Property, Plant and Equipment, Gross of $94.33 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-07-29
- 2026-06-30: Property, Plant and Equipment, Gross $94.33M.
- 2026-03-31: Property, Plant and Equipment, Gross $92.47M.
- 2025-12-31: Property, Plant and Equipment, Gross $91.75M.
- 2025-06-30: Property, Plant and Equipment, Gross $91.25M; Property, Plant and Equipment, Gross as first filed $90.29M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $94.33M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $92.47M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $91.75M 10-Q · filed 2026-07-29 | |
| 2025-06-30 | $91.25M 10-Q · filed 2025-11-05 | $90.29M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $88.11M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $85.28M 10-K · filed 2026-03-03 | |
| 2023-12-31 | $81.43M 10-K · filed 2025-03-17 | $93.87M 10-K · filed 2024-03-15 |
| 2022-12-31 | $94.46M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $87.19M 10-K · filed 2023-03-16 | |
| 2020-12-31 | $85.30M 10-K · filed 2022-03-11 | |
| 2019-12-31 | $79.29M 10-K/A · filed 2021-04-26 | |
| 2018-12-31 | $78.18M 10-K · filed 2020-03-06 | |
| 2017-12-31 | $76.37M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $79.07M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $64.65M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $57.67M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $54.67M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $53.67M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $53.62M 10-K · filed 2016-03-10 | $53.62M 10-K · filed 2015-03-13 |
| 2014-09-30 | $53.38M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $53.14M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $52.77M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $52.41M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $52.07M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $51.62M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $51.57M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $52.38M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $52.14M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $51.92M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $51.54M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $50.85M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $50.68M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $50.46M 10-Q/A · filed 2011-08-10 | |
| 2010-12-31 | $49.70M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |